The efficacy of combination cisplatinum, adriamycin and cyclophosphamide in malignant thymoma.
Shiu
W
W
Department of Clinical Oncology, Chinese University of Hong Kong, Prince of Wales Hospital.
Teo
P
P
Wong
K
K
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000150:complications*; D013945:Thymoma / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D013953:Thymus Neoplasms / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D014057:Tomography, X-Ray Computed
D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin